Gleason Score News and Research

RSS
Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Higher doses of radiation do not translate into longer survival for prostate cancer patients

Higher doses of radiation do not translate into longer survival for prostate cancer patients

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

Men who follow Mediterranean diet have lower risk of aggressive prostate cancer, study finds

PET scans can predict prostate cancer patients’ response to salvage radiation treatment

PET scans can predict prostate cancer patients’ response to salvage radiation treatment

New CSHL method pinpoints which prostate tumors pose fatal threat before surgery

New CSHL method pinpoints which prostate tumors pose fatal threat before surgery

Common genetic fusion event could help identify patients with low-risk prostate cancer

Common genetic fusion event could help identify patients with low-risk prostate cancer

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate cancer screening reduces cancer deaths finds new analysis

Prostate cancer screening reduces cancer deaths finds new analysis

Surgery may not prolong life in men with early-stage prostate cancer

Surgery may not prolong life in men with early-stage prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Protein testing may become potential tool to detect prostate cancer

Protein testing may become potential tool to detect prostate cancer

New genetic test may give men better view on how to deal with prostate cancer risk

New genetic test may give men better view on how to deal with prostate cancer risk

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men